mucinous epithelial ovarian cancer(English)

• may be benign, borderline, or malignant. Malignant tumors may be primary or metastatic. Differentiation between primary and metastatic involvement of the ovary is critical for optimal patient management. Even among skilled pathologists, this distinction can be problematic, as can the distinction between borderline ovarian tumour of intestinal type and well-differentiated invasive primary mucinous ovarian carcinoma. mEOC is now characterized as a type I tumor with an identifiable stepwise progression from a premalignant lesion, through non-invasive, to invasive malignancy
• HER2, KRAS, EOC
• Oncology, Woman /female
• https://doi.org…3/annonc/mdw087